Found 286 matching trials
Enhancement of Stroke Rehabilitation With Levodopa PHASE3 Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg c...
Show More Status
Active Not Recruiting
Location
Kantonsspital Aarau, Neurozentrum
Learn More & Join Trial
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence PHASE2 Cocaine dependence is a major public health problem; an effective primary t...
Show More Location
University of Texas Health Science Center
Learn More & Join Trial
Chinese Herbal Medicine Treatment as Adjunct Therapy for Parkinson's Disease PHASE2 Background: Parkinson's disease (PD) is a prevalent and debilitating condit...
Show More Location
Department of Medicine, Queen Elizabeth Hospital
Learn More & Join Trial
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease PHASE2 This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Show More Learn More & Join Trial
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease PHASE3 Parkinson's disease (PD) is a neurological condition, which affects the bra...
Show More Location
University of Alabama at Birmingham - Main /ID# 216595
Learn More & Join Trial
A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia. PHASE2 This is a multicenter, randomized, double blind, pramipexole-controlled par...
Show More Location
Site Reference ID/Investigator# 45433
Learn More & Join Trial
Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease PHASE2 Traditionally amantadine is used at the beginning of Parkinson Disease (PD)...
Show More Location
CHG Aix en Provence
Learn More & Join Trial
Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease PHASE3 The purpose of this study is to evaluate the efficacy and safety of two dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics PHASE1 To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Show More Location
Human Pharmacology Unit (UFH)
Learn More & Join Trial
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 PHASE3 This is a 1-year, open-label, long-term safety extension for patients who h...
Show More Location
Kyowa Pharmaceutical Inc.
Learn More & Join Trial